[Edaily Reporter Park Jung-Soo ] EuBiologics Co., Ltd.(206650)announced on the 14th that it has signed a contract with UNICEF to supply oral cholera vaccines (UbiCol-S) worth approximately 10.1 billion won. The contract amount represents 6.77% of last year’s revenue, and the contract period runs through September 12.
Disclosure Plus
EuBiologics Co., Ltd. Signs 10.1 Billion Won Contract with UNICEF to Supply Oral Cholera Vaccines
Park Jung-Soo
2026-07-14 11:00:01
Economy
Corporation
IT·Science
Economy
Once They Landed Their 'First Customer,' Investment Followed… Securing a Customer Base Is the Formula for Growth
“Technological capability does not automatically guarantee funding.” This is a common saying in the energy and climate tech ecosystem. This is because technology development takes a long time, and com…
Corporation
"From Gaming Pop-Ups to Virtual Idol Concerts"... Department Stores Step Up Efforts to Attract Gen Z Customers
The domestic department store industry is actively working to attract Gen Z customers (born in the mid-to-late 1990s through the early 2000s). They are attracting young people through pop-up stores fe…
IT·Science
ST Pharm Co., Ltd. Reports Third-Quarter Revenue of 97.6 Billion Won… Up 19% Year-Over-Year
ST Pharm Co., Ltd.(237690)continued to post year-over-year revenue growth in the third quarter of this year, driven by its oligonucleotide (oligo) commercialization project and expanded sales in its s…
